Fontana, R., Bregni, M., Cipponi, A., Raccosta, L., Rainelli, C., Maggioni, D., . . . Russo, V. (2009). Peripheral blood lymphocytes genetically modified to express the self/tumor antigen MAGE-A3 induce antitumor immune responses in cancer patients. Blood, 113(8), 1651. https://doi.org/10.1182/blood-2008-07-168666
Chicago-Zitierstil (17. Ausg.)Fontana, Raffaella, et al. "Peripheral Blood Lymphocytes Genetically Modified to Express the Self/tumor Antigen MAGE-A3 Induce Antitumor Immune Responses in Cancer Patients." Blood 113, no. 8 (2009): 1651. https://doi.org/10.1182/blood-2008-07-168666.
MLA-Zitierstil (9. Ausg.)Fontana, Raffaella, et al. "Peripheral Blood Lymphocytes Genetically Modified to Express the Self/tumor Antigen MAGE-A3 Induce Antitumor Immune Responses in Cancer Patients." Blood, vol. 113, no. 8, 2009, p. 1651, https://doi.org/10.1182/blood-2008-07-168666.